Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence.

Saved in:
Bibliographic Details
Title: Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence.
Authors: Yiu CH; The University of Sydney School of Pharmacy, Camperdown, Sydney, NSW, Australia. chin.yiu@sydney.edu.au.; Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, St Leonards, Sydney, NSW, Australia. chin.yiu@sydney.edu.au., Winardi K; Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, St Leonards, Sydney, NSW, Australia.; Laboratory of Ageing and Pharmacology, Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, St Leonards, Sydney, NSW, Australia., Lu CY; The University of Sydney School of Pharmacy, Camperdown, Sydney, NSW, Australia.; Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, St Leonards, Sydney, NSW, Australia.; Department of Pharmacy, Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia.
Source: Current oncology reports [Curr Oncol Rep] 2026 May 14; Vol. 28 (1). Date of Electronic Publication: 2026 May 14.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first